How to buy Amarin (AMRN) shares in Australia

Learn how to easily invest in Amarin shares.

Amarin Corporation plc
- $0.09 ( - 1.79%)

We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!

Amarin Corporation plc is a biotechnology business with stocks listed in the US. Amarin shares (AMRN) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was US$4.76 – a decrease of 5.74% over the previous week. Here's how to invest if you're based in Australia.

How to buy shares in Amarin

  1. Compare share trading platforms. To buy shares in a US company from Australia you'll need to find a trading platform that offers access to US stock markets. If you're just starting out, look for a platform with low brokerage and foreign exchange fees.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Amarin. Find the share by name or ticker symbol: AMRN. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Amarin reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of US$5.65, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs. You may be able to buy a fractional share of Amarin, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Amarin. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Amarin stock price (NASDAQ:AMRN)

Use our graph to track the performance of AMRN stocks over time.

Amarin shares at a glance

Information last updated 2021-10-23.
52-week rangeUS$3.84 - US$9.25
50-day moving average US$5.1446
200-day moving average US$4.905
Target priceUS$10.75
PE ratio 500
Dividend yield N/A (0%)
Earnings per share (TTM) US$0.01

Where to buy Amarin stock

Name Product Standard brokerage for US shares Currency conversion fee Markets
eToro (global stocks)
50 pips (US$0.50 for every AU$100 exchanged)
Global shares, US shares, ETFs
Zero brokerage share trading on US, Hong Kong and European stocks with trades as low as $50.
Note: This broker offers CFDs which are volatile investment products and most clients lose money trading CFDs with this provider.
Join the world’s biggest social trading network when you trade stocks, commodities and currencies from the one account.
IG Share Trading
ASX shares, Global shares
$0 brokerage for US and global shares plus get an active trader discount of $5 commission on Australian shares.
Enjoy some of the lowest brokerage fees on the market when trading Australian shares, international shares, plus get access to 24-hour customer support.
Superhero share trading
50 pips (US$0.50 for every AU$100 exchanged)
ASX shares, US shares
Australia’s lowest-cost broker for ASX shares and ETFs.
Pay zero brokerage on US stocks and all ETFs and just $5 (flat fee) to trade Australian shares from your mobile or desktop.
SelfWealth (Basic account)
ASX shares, US shares
Trade ASX and US shares for a flat fee of $9.50, regardless of the trade size.
New customers receive free access to Community Insights with SelfWealth Premium for the first 90 days. Follow other investors and benchmark your portfolio performance.
Saxo Capital Markets (Classic account)
ASX shares, Global shares, Forex, CFDs, Margin trading, Options trading, ETFs
Access 19,000+ stocks on 40+ exchanges worldwide
Low fees for Australian and global share trading, no inactivity fees, low currency conversion fee and optimised for mobile.
CMC Markets Invest
ASX shares, Global shares, mFunds, ETFs
$0 brokerage on global shares including US, UK and Japan markets.
Trade up to 9,000 products, including shares, ETFs and managed funds, plus access up to 15 major global and Australian stock exchanges.

Compare up to 4 providers

The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.

Is it a good time to buy Amarin stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Amarin share growth calculator


Use the fields above to explore the returns from a historical investment. Please refer to the charts further up this page to see performance over 5 years, or other periods. Past performance doesn't indicate future results. Capital is at risk.

Considering buying Amarin shares?

Before you consider Amarin, you'll want to hear this.
Ticker Nerd uses advanced software to track hundreds of signals and data points to find stocks before they blow up. You can get the next two hot stocks they find sent to your inbox for free.

Show me how

Amarin price performance over time

Historical closes compared with the last close of $4.76

1 week (2021-10-19) -5.74%
1 month (2021-09-24) -11.85%
3 months (2021-07-26) 20.81%
6 months (2021-04-26) -8.11%
1 year (2020-10-26) -2.06%
2 years (2019-10-25) -71.24%
3 years (2018-10-26) -78.32%
5 years (2016-10-26) 37.97%

Is Amarin under- or over-valued?

Valuing Amarin stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Amarin's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Amarin's P/E ratio

Amarin's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 500x. In other words, Amarin shares trade at around 500x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Amarin's EBITDA

Amarin's EBITDA (earnings before interest, taxes, depreciation and amortisation) is US$10 million (£0.0 million).

The EBITDA is a measure of a Amarin's overall financial performance and is widely used to measure a its profitability.

Amarin financials

Revenue TTM US$620.4 million
Operating margin TTM 1.24%
Gross profit TTM US$482.6 million
Return on assets TTM 0.49%
Return on equity TTM 0.69%
Profit margin 0.7%
Book value 1.633
Market capitalisation US$2 billion

TTM: trailing 12 months

Shorting Amarin shares

There are currently 17.3 million Amarin shares held short by investors – that's known as Amarin's "short interest". This figure is 1.4% up from 17.0 million last month.

There are a few different ways that this level of interest in shorting Amarin shares can be evaluated.

Amarin's "short interest ratio" (SIR)

Amarin's "short interest ratio" (SIR) is the quantity of Amarin shares currently shorted divided by the average quantity of Amarin shares traded daily (recently around 2.7 million). Amarin's SIR currently stands at 6.42. In other words for every 100,000 Amarin shares traded daily on the market, roughly 6420 shares are currently held short.

However Amarin's short interest can also be evaluated against the total number of Amarin shares, or, against the total number of tradable Amarin shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Amarin's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 Amarin shares in existence, roughly 40 shares are currently held short) or 0.0476% of the tradable shares (for every 100,000 tradable Amarin shares, roughly 48 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Amarin.

Find out more about how you can short Amarin stock.

Amarin share dividends

We're not expecting Amarin to pay a dividend over the next 12 months.

Have Amarin's shares ever split?

Amarin's shares were split on a 1:10 basis on 17 January 2008. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Amarin shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Amarin shares which in turn could have impacted Amarin's share price.

Amarin share price volatility

Over the last 12 months, Amarin's shares have ranged in value from as little as US$3.84 up to US$9.25. A popular way to gauge a stock's volatility is its "beta".

AMRN.US volatility(beta: 2.25)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Amarin's is 2.2524. This would suggest that Amarin's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Amarin overview

Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally to wholesalers and specialty pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, and eicosapentaenoic acid. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder only provides general advice and factual information, so consider your own circumstances, or seek advice before you decide to act on our content. By submitting a question, you're accepting our Terms of Use, Disclaimer & Privacy Policy and Privacy & Cookies Policy.
Go to site